[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Clinical Outcomes of Atrial Fibrillation in Aortic Aneurysm Patients: Insights from the National Inpatient Sample",
    "section": "",
    "text": "Reference Papers:\n\nKumi et al. 2024\n\nStudy Objective: Examine the impact of atrial fibrillation on in-hospital mortality and length of stay among inpatient admissions with a principal diagnosis of aortic aneurysm (AA).\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with a principal diagnosis of AA.\nAortic Aneurysm + Atrial Fibrillation Categories:\n\nAortic Aneurysm with Atrial Fibrillation\nAortic Aneurysm without Atrial Fibrillation\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nStatistical Analysis: Multiple logistic and linear regression to determine the independent association of atrial fibrillation with in-hospital mortality and length of stay, respectively, adjusted for:\n\nDemographics: Age, sex, race, residential income, insurance, hospital region, hospital bedsize, hospital location, and teaching status.\nMedical History: Hypertension, cerebrovascular disease, heart failure, diabetes mellitus, chronic kidney disease, chronic obstructive pulmonary disease, and HIV/AIDS.\nComorbidities: Charlson comorbidity index.\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Clinical Outcomes of Atrial Fibrillation in Aortic Aneurysm Patients: Insights from the National Inpatient Sample",
    "section": "",
    "text": "Reference Papers:\n\nKumi et al. 2024\n\nStudy Objective: Examine the impact of atrial fibrillation on in-hospital mortality and length of stay among inpatient admissions with a principal diagnosis of aortic aneurysm (AA).\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with a principal diagnosis of AA.\nAortic Aneurysm + Atrial Fibrillation Categories:\n\nAortic Aneurysm with Atrial Fibrillation\nAortic Aneurysm without Atrial Fibrillation\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nStatistical Analysis: Multiple logistic and linear regression to determine the independent association of atrial fibrillation with in-hospital mortality and length of stay, respectively, adjusted for:\n\nDemographics: Age, sex, race, residential income, insurance, hospital region, hospital bedsize, hospital location, and teaching status.\nMedical History: Hypertension, cerebrovascular disease, heart failure, diabetes mellitus, chronic kidney disease, chronic obstructive pulmonary disease, and HIV/AIDS.\nComorbidities: Charlson comorbidity index.\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Clinical Outcomes of Atrial Fibrillation in Aortic Aneurysm Patients: Insights from the National Inpatient Sample",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall, N = 200,2501\nAortic Aneurysm without Atrial Fibrillation, N = 161,2201\nAortic Aneurysm with Atrial Fibrillation, N = 39,0301\np-value2\n\n\n\n\nAge, y\n70 (12)\n69 (12)\n73 (11)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n0.2\n\n\n    Female\n59,240 (30%)\n47,475 (29%)\n11,765 (30%)\n\n\n\n\n    Male\n141,010 (70%)\n113,745 (71%)\n27,265 (70%)\n\n\n\n\nRace\n\n\n\n\n\n\n&lt;0.001\n\n\n    White\n150,495 (77%)\n119,555 (76%)\n30,940 (82%)\n\n\n\n\n    Asian or Pacific Islander\n5,250 (2.7%)\n4,145 (2.6%)\n1,105 (2.9%)\n\n\n\n\n    Black\n22,075 (11%)\n19,185 (12%)\n2,890 (7.6%)\n\n\n\n\n    Hispanic\n10,695 (5.5%)\n8,865 (5.7%)\n1,830 (4.8%)\n\n\n\n\n    Native American\n740 (0.4%)\n620 (0.4%)\n120 (0.3%)\n\n\n\n\n    Other\n5,130 (2.6%)\n4,155 (2.7%)\n975 (2.6%)\n\n\n\n\nCharlson comorbidity index\n2.63 (1.70)\n2.54 (1.66)\n2.98 (1.80)\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n&lt;0.001\n\n\n    $1 - $51,999\n54,180 (28%)\n45,185 (29%)\n8,995 (23%)\n\n\n\n\n    $52,000 - $65,999\n53,525 (27%)\n43,500 (27%)\n10,025 (26%)\n\n\n\n\n    $66,000 - $87,999\n48,415 (25%)\n38,300 (24%)\n10,115 (26%)\n\n\n\n\n    $88,000 or more\n40,700 (21%)\n31,440 (20%)\n9,260 (24%)\n\n\n\n\nExpected primary payer\n\n\n\n\n\n\n&lt;0.001\n\n\n    Private\n47,895 (24%)\n40,020 (25%)\n7,875 (20%)\n\n\n\n\n    Medicaid\n13,350 (6.7%)\n11,680 (7.3%)\n1,670 (4.3%)\n\n\n\n\n    Medicare\n133,140 (67%)\n104,660 (65%)\n28,480 (73%)\n\n\n\n\n    Other\n5,610 (2.8%)\n4,630 (2.9%)\n980 (2.5%)\n\n\n\n\nHospital region\n\n\n\n\n\n\n&lt;0.001\n\n\n    Midwest\n49,140 (25%)\n39,265 (24%)\n9,875 (25%)\n\n\n\n\n    Northeast\n35,830 (18%)\n28,735 (18%)\n7,095 (18%)\n\n\n\n\n    South\n77,960 (39%)\n63,855 (40%)\n14,105 (36%)\n\n\n\n\n    West\n37,320 (19%)\n29,365 (18%)\n7,955 (20%)\n\n\n\n\nHospital bedsize\n\n\n\n\n\n\n&lt;0.001\n\n\n    Large\n131,165 (66%)\n104,555 (65%)\n26,610 (68%)\n\n\n\n\n    Medium\n46,390 (23%)\n37,925 (24%)\n8,465 (22%)\n\n\n\n\n    Small\n22,695 (11%)\n18,740 (12%)\n3,955 (10%)\n\n\n\n\nHospital location and teaching status\n\n\n\n\n\n\n&lt;0.001\n\n\n    Rural\n6,100 (3.0%)\n5,170 (3.2%)\n930 (2.4%)\n\n\n\n\n    Urban, non-teaching\n22,565 (11%)\n18,685 (12%)\n3,880 (9.9%)\n\n\n\n\n    Urban, teaching\n171,585 (86%)\n137,365 (85%)\n34,220 (88%)\n\n\n\n\nHypertension\n166,000 (83%)\n132,060 (82%)\n33,940 (87%)\n&lt;0.001\n\n\nCerebrovascular disease\n17,455 (8.7%)\n13,190 (8.2%)\n4,265 (11%)\n&lt;0.001\n\n\nHeart failure\n36,420 (18%)\n23,845 (15%)\n12,575 (32%)\n&lt;0.001\n\n\nDiabetes mellitus\n35,950 (18%)\n28,625 (18%)\n7,325 (19%)\n0.042\n\n\nChronic kidney disease\n41,105 (21%)\n31,270 (19%)\n9,835 (25%)\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n60,135 (30%)\n47,770 (30%)\n12,365 (32%)\n&lt;0.001\n\n\nHIV/AIDS\n1,420 (0.7%)\n1,135 (0.7%)\n285 (0.7%)\n0.8\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Wilcoxon rank-sum test for complex survey samples; chi-squared test with Rao & Scott’s second-order correction"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Clinical Outcomes of Atrial Fibrillation in Aortic Aneurysm Patients: Insights from the National Inpatient Sample",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\n\n\n\n\n\n\n\n\nCharacteristic\nOverall, N = 200,2501\nAortic Aneurysm without Atrial Fibrillation, N = 161,2201\nAortic Aneurysm with Atrial Fibrillation, N = 39,0301\np-value2\n\n\n\n\nDied during hospitalization\n12,550 (6.3%)\n9,660 (6.0%)\n2,890 (7.4%)\n&lt;0.001\n\n\nLength of stay (days)\n5.8 (8.2)\n5.3 (7.9)\n7.9 (8.8)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n200,987 (253,315)\n190,435 (253,243)\n244,613 (248,923)\n&lt;0.001\n\n\n\n1 n (%); Mean (SD)\n\n\n2 chi-squared test with Rao & Scott’s second-order correction; Wilcoxon rank-sum test for complex survey samples"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Clinical Outcomes of Atrial Fibrillation in Aortic Aneurysm Patients: Insights from the National Inpatient Sample",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR1\n95% CI1\np-value\n\n\n\n\nAtrial fibrillation categories\n\n\n\n\n\n\n\n\n    Aortic Aneurysm without Atrial Fibrillation\n—\n—\n\n\n\n\n    Aortic Aneurysm with Atrial Fibrillation\n1.09\n0.98, 1.21\n0.11\n\n\nAge, y\n1.03\n1.02, 1.03\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.57\n0.52, 0.62\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.23\n0.97, 1.57\n0.084\n\n\n    Black\n1.15\n1.00, 1.33\n0.052\n\n\n    Hispanic\n1.08\n0.90, 1.30\n0.4\n\n\n    Native American\n0.88\n0.41, 1.90\n0.7\n\n\n    Other\n1.25\n0.96, 1.63\n0.10\n\n\nCharlson comorbidity index\n1.25\n1.19, 1.32\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.96\n0.85, 1.08\n0.5\n\n\n    $66,000 - $87,999\n0.96\n0.85, 1.08\n0.5\n\n\n    $88,000 or more\n0.83\n0.73, 0.96\n0.009\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.05\n0.85, 1.29\n0.6\n\n\n    Medicare\n0.71\n0.63, 0.80\n&lt;0.001\n\n\n    Other\n0.91\n0.69, 1.22\n0.5\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.15\n1.00, 1.33\n0.050\n\n\n    South\n1.03\n0.91, 1.17\n0.6\n\n\n    West\n1.15\n1.00, 1.33\n0.052\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.01\n0.90, 1.12\n0.9\n\n\n    Small\n1.05\n0.91, 1.20\n0.5\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.88\n0.68, 1.13\n0.3\n\n\n    Urban, teaching\n0.87\n0.69, 1.09\n0.2\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.49\n0.44, 0.54\n&lt;0.001\n\n\nCerebrovascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.80\n1.57, 2.06\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.30\n1.15, 1.47\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.56\n0.48, 0.64\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.72\n0.62, 0.84\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.60\n0.53, 0.67\n&lt;0.001\n\n\nHIV/AIDS\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.36\n0.21, 0.61\n&lt;0.001\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Clinical Outcomes of Atrial Fibrillation in Aortic Aneurysm Patients: Insights from the National Inpatient Sample",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI1\np-value\n\n\n\n\nAtrial fibrillation categories\n\n\n\n\n\n\n\n\n    Aortic Aneurysm without Atrial Fibrillation\n—\n—\n\n\n\n\n    Aortic Aneurysm with Atrial Fibrillation\n2.5\n2.3, 2.7\n&lt;0.001\n\n\nAge, y\n-0.09\n-0.10, -0.09\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n-0.92\n-1.1, -0.74\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.1\n0.60, 1.7\n&lt;0.001\n\n\n    Black\n1.7\n1.4, 2.0\n&lt;0.001\n\n\n    Hispanic\n1.3\n0.88, 1.7\n&lt;0.001\n\n\n    Native American\n-0.20\n-1.1, 0.74\n0.7\n\n\n    Other\n0.95\n0.46, 1.4\n&lt;0.001\n\n\nCharlson comorbidity index\n0.94\n0.79, 1.1\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-0.06\n-0.28, 0.16\n0.6\n\n\n    $66,000 - $87,999\n0.00\n-0.24, 0.25\n&gt;0.9\n\n\n    $88,000 or more\n0.09\n-0.17, 0.35\n0.5\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.8\n1.3, 2.3\n&lt;0.001\n\n\n    Medicare\n-0.18\n-0.41, 0.05\n0.13\n\n\n    Other\n0.48\n-0.09, 1.1\n0.10\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.85\n0.49, 1.2\n&lt;0.001\n\n\n    South\n0.62\n0.35, 0.90\n&lt;0.001\n\n\n    West\n0.47\n0.19, 0.75\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-1.4\n-1.6, -1.1\n&lt;0.001\n\n\n    Small\n-1.6\n-1.9, -1.4\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.71\n0.32, 1.1\n&lt;0.001\n\n\n    Urban, teaching\n2.2\n1.8, 2.6\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.0\n-1.3, -0.73\n&lt;0.001\n\n\nCerebrovascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3.4\n3.0, 3.9\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.2\n0.85, 1.5\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.7\n-2.0, -1.4\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.50\n-0.89, -0.11\n0.011\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.1\n-1.4, -0.91\n&lt;0.001\n\n\nHIV/AIDS\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-5.2\n-6.4, -4.0\n&lt;0.001\n\n\n\n1 CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI1\np-value\n\n\n\n\nAtrial fibrillation categories\n\n\n\n\n\n\n\n\n    Aortic Aneurysm without Atrial Fibrillation\n—\n—\n\n\n\n\n    Aortic Aneurysm with Atrial Fibrillation\n47,941\n40,621, 55,261\n&lt;0.001\n\n\nAge, y\n-2,783\n-3,131, -2,435\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n6,361\n1,199, 11,522\n0.016\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n26,644\n2,981, 50,307\n0.027\n\n\n    Black\n23,852\n14,251, 33,452\n&lt;0.001\n\n\n    Hispanic\n40,239\n24,788, 55,690\n&lt;0.001\n\n\n    Native American\n-14,332\n-43,291, 14,626\n0.3\n\n\n    Other\n45,354\n23,988, 66,720\n&lt;0.001\n\n\nCharlson comorbidity index\n16,310\n12,197, 20,422\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n6,209\n-507, 12,925\n0.070\n\n\n    $66,000 - $87,999\n6,262\n-1,641, 14,165\n0.12\n\n\n    $88,000 or more\n19,413\n9,054, 29,772\n&lt;0.001\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n14,948\n-652, 30,547\n0.060\n\n\n    Medicare\n327\n-7,732, 8,387\n&gt;0.9\n\n\n    Other\n16,937\n-4,483, 38,356\n0.12\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n34,073\n18,832, 49,314\n&lt;0.001\n\n\n    South\n33,133\n25,613, 40,653\n&lt;0.001\n\n\n    West\n107,084\n82,039, 132,129\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-32,361\n-42,797, -21,925\n&lt;0.001\n\n\n    Small\n-38,304\n-49,943, -26,666\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n48,425\n37,048, 59,803\n&lt;0.001\n\n\n    Urban, teaching\n75,489\n66,329, 84,648\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-38,978\n-48,329, -29,626\n&lt;0.001\n\n\nCerebrovascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n99,018\n82,127, 115,909\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n40,971\n26,631, 55,312\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-28,123\n-36,201, -20,046\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-7,887\n-21,650, 5,876\n0.3\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-24,755\n-31,262, -18,247\n&lt;0.001\n\n\nHIV/AIDS\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-118,687\n-154,398, -82,977\n&lt;0.001\n\n\n\n1 CI = Confidence Interval"
  }
]